Dexcom Plans European Launch Of G7 CGM; Hopes To Earn 510(k) This Summer

Dexcom received a CE mark for the G7 system in Europe and is awaiting a 510(k) clearance from the US FDA. The G7 is smaller and easier-to-use than the company's G6 CGM and will be more competitive with Abbott's FreeStyle Libre 3 CGM

Blood glucose and insulin molecules • Source: Alamy

DexCom plans to launch its G7 continuous glucose monitoring (CGM) system in Europe in the next few weeks, following receipt of a CE mark for the next-generation system, which was developed in collaboration with Verily.

The company said it is working closely with insulin pump manufacturers to integrate the G7 into automated insulin delivery systems as quickly as possible and will announce more details on...

More from Diabetic Care

More from Device Area